Document is current
Any future updates will be listed below
-
Authors
Gärtner, Christiane
Haaf, Monique E. ten
Akkerhuis, K. Martijn
Oemrawsingh, Rohit M.
van Schaik, Ron H.
de Rijke, Yolanda B.
Kardys, Isabella
Appelman, Yolande
Boersma, Eric
-
Funding
Funding for this research was provided by:
Netherlands Heart Foundation (2007B012)
Netherlands Heart Institute-Interuniversity Cardiology Institute of the Netherlands (071.01)
Working Group on Cardiovascular Research Netherlands
Eli Lilly, the Netherlands
- License Information
-
More Information
Article History
Received: 10 June 2025
Accepted: 28 November 2025
First Online: 10 December 2025
Declarations
:
: IK received travel reimbursement from Olink and SomaLogic. The other authors declare that they have no competing interests.
: BIOMArCS was conducted in accordance with the Declaration of Helsinki. The study protocol was approved by the institutional review board of the Erasmus MC (approval nr. MEC-2007-185), which decision was adopted by all other participating centers in accordance with Dutch law. All study participants provided written informed consent. BIOMArCS is registered in The Netherlands Trial Register under the unique identifiers NTR1106 and NTR1698.
